CureVac N.V. Files Lawsuit Against BioNTech for Infringement
CureVac N.V. (CVAC), a company that develops therapeutics based on messenger ribonucleic acid (mRNA), has moved to assert its intellectual property rights that have been accumulated over more than two decades of pioneering work in mRNA technology. Technology that contributed to COVID-19 vaccine development.
The Company acknowledged filing a lawsuit . . .